Related Experiment Video
Updated: May 6, 2026

08:59
T and B Cell Receptor Immune Repertoire Analysis using Next-generation Sequencing
Published on: January 12, 2021
8.3K
Machine learning-based detection of adventitious microbes in T-cell therapy cultures using long-read sequencing
James P B Strutt1, Meenubharathi Natarajan1, Elizabeth Lee1
1Singapore-MIT Alliance for Research and Technology , Singapore, Singapore.
Microbiology Spectrum
|August 30, 2023
Summary
This study introduces a rapid nanopore sequencing method combined with machine learning to detect microbial contamination in cell therapies, significantly reducing testing time from 14 days to hours for improved patient safety.
Area of Science:
- Microbiology
- Genomics
- Bioinformatics
Background:
- Cell therapy product safety relies on rigorous sterility testing.
- Current compendial sterility tests (USP <71>) are time-consuming, taking 7-14 days.
- Rapid detection of low-abundance microbial contaminants is crucial for cell therapy manufacturing.
Purpose of the Study:
- To develop a rapid, untargeted method for sensitive microbial contaminant detection in cell therapies.
- To utilize long-read sequencing and machine learning for sterility assessment.
- To reduce the time required for microbial testing in cell therapy production.
Main Methods:
- Developed a long-read sequencing workflow using Oxford Nanopore Technologies MinION.
- Employed 16S and 18S amplicon sequencing for microbial detection.
- Utilized metagenomic classification and an XGBoost machine learning model for contaminant identification and sterility determination.
Main Results:
- Achieved sensitive detection of microbial contaminants down to 10 colony-forming units (CFU)/mL.
- The developed pipeline accurately identified microbial species and assessed sample sterility status.
- Demonstrated the capability to detect USP <71> organisms and other microbial species.
Conclusions:
- Coupling long-read sequencing with machine learning provides a rapid and accurate method for cell therapy sterility testing.
- This novel approach significantly shortens detection time compared to traditional methods.
- The method enhances the safety and efficiency of cell therapy manufacturing, benefiting patient outcomes.

